Literature DB >> 26205744

[Prolonged topical natamycin 5 % therapy before and after keratoplasty for Fusarium keratitis].

N Cvetkova1, J Köstler2, P Prahs3, H Helbig3, T Dietrich-Ntoukas3,4.   

Abstract

CASE REPORT: A 69-year-old female patient presented with a therapy-resistant corneal ulcer due to contact lenses, which had been present in the left eye for 1 month. The best corrected visual acuity at the first visit was 0.2. Keratitis with a central corneal ulcer was found. A corneal curettage was performed followed by inpatient therapy with antibiotic eye drops. The first PCR result was negative and the microbiological culture was sterile after 48 h. The clinical findings improved during the hospital stay. There was a decrease in the size of the corneal ulcer and an increase of best corrected visual acuity up to 0.4 so that the patient was discharged. COURSE: After 8 weeks the patient presented again with a painful eye and visual decline to 0.1. The left eye showed a fulminant keratitis with corneal abscess so that a second course of therapy was initiated. The PCR of the second corneal curettage was positive for Fusarium. Antifungal therapy with natamycin 5 % eye drops (via the international pharmacy) and systemic antifungal therapy with voriconazole (2 × 200 mg) were initiated. Due to personal circumstances the patient rejected corneal transplantation, therefore, local and systemic antifungal outpatient treatment was continued for another 2 months until keratoplasty à chaud of the left eye could be performed. At this time there was a clear reduction of inflammation but a descemetocele developed. The patient was treated with local and systemic antifungal therapy (under control of liver and kindney parameters in blood) for 3 months postoperatively in addition to administration of local and systemic steroids. DIAGNOSTICS: In cases of therapy-resistant keratitis, a Fusarium keratitis should always be considered. Corneal curettage ahead of therapy is very important. THERAPY: Natamycin 5 % eye drops are the first choice of topical antifungal medication in cases of Fusarium keratitis. Even though intensive local and systemic therapy are performed, patients often require corneal transplantation. Due to a high rate of recurrence a longer local and systemic antifungal therapy is required.
CONCLUSION: In the case described here, there was a clear corneal graft without Fusarium recurrence 1 year after surgery and it is presumed the prolonged antifungal therapy before and after surgery was an important factor for this clinical outcome.

Entities:  

Keywords:  Antimycotic therapy; Corneal ulcer; Curettage; Keratitis; Recurrence

Mesh:

Substances:

Year:  2016        PMID: 26205744     DOI: 10.1007/s00347-015-0111-x

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  9 in total

1.  MYCOTIC KERATITIS.

Authors:  H E KAUFMAN; R M WOOD
Journal:  Am J Ophthalmol       Date:  1965-06       Impact factor: 5.258

Review 2.  [Anti-infective therapy of the eye -- part 3: mycotic infections].

Authors:  W Behrens-Baumann
Journal:  Klin Monbl Augenheilkd       Date:  2005-08       Impact factor: 0.700

3.  Mechanism of drug failure in fusarium keratitis, 2004-2006.

Authors:  John D Bullock; B Laurel Elder; Ronald E Warwar; Shane A Snyder; Ioana E Sizemore
Journal:  N Engl J Med       Date:  2014-01-02       Impact factor: 91.245

4.  Comparison of techniques for culturing corneal ulcers.

Authors:  W H Benson; J D Lanier
Journal:  Ophthalmology       Date:  1992-05       Impact factor: 12.079

5.  Re-appraisal of topical 1% voriconazole and 5% natamycin in the treatment of fungal keratitis in a randomised trial.

Authors:  Savitri Sharma; Sujata Das; Ajoy Virdi; Merle Fernandes; Srikant K Sahu; Nagendra Kumar Koday; Md Hasnat Ali; Prashant Garg; Swapna R Motukupally
Journal:  Br J Ophthalmol       Date:  2015-03-04       Impact factor: 4.638

6.  Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution.

Authors:  Douglas C Chang; Gavin B Grant; Kerry O'Donnell; Kathleen A Wannemuehler; Judith Noble-Wang; Carol Y Rao; Lara M Jacobson; Claudia S Crowell; Rodlescia S Sneed; Felicia M T Lewis; Joshua K Schaffzin; Marion A Kainer; Carol A Genese; Eduardo C Alfonso; Dan B Jones; Arjun Srinivasan; Scott K Fridkin; Benjamin J Park
Journal:  JAMA       Date:  2006-08-23       Impact factor: 56.272

Review 7.  [Keratomycosis: diagnosis and therapy].

Authors:  W Behrens-Baumann
Journal:  Ophthalmologe       Date:  2009-05       Impact factor: 1.059

Review 8.  Fungal keratitis.

Authors:  C S Foster
Journal:  Infect Dis Clin North Am       Date:  1992-12       Impact factor: 5.982

9.  Early keratectomy in the treatment of moderate Fusarium keratitis.

Authors:  Hsin-Chiung Lin; Ja-Liang Lin; Dan-Tzu Lin-Tan; Hui-Kang Ma; Hung-Chi Chen
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

  9 in total
  2 in total

1.  Fusarium Keratitis in Germany.

Authors:  Grit Walther; Serena Stasch; Kerstin Kaerger; Axel Hamprecht; Mathias Roth; Oliver A Cornely; Gerd Geerling; Colin R Mackenzie; Oliver Kurzai; Marie von Lilienfeld-Toal
Journal:  J Clin Microbiol       Date:  2017-07-26       Impact factor: 5.948

2.  Malignant Keratitis Caused by a Highly-Resistant Strain of Fusarium Tonkinense from the Fusarium Solani Complex.

Authors:  Jens Schrecker; Berthold Seitz; Tim Berger; Loay Daas; Wolfgang Behrens-Baumann; Claudia Auw-Hädrich; Sabine Schütt; Sabine Kerl; Sascha Rentner-Andres; Herbert Hof
Journal:  J Fungi (Basel)       Date:  2021-12-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.